1 November 2024 in Addictive Behaviors
Background: Research has demonstrated positive associations between adverse childhood experiences (ACEs) and substance use behaviours in young adults. However, many of these are based on cross-sectional data. The pathway between ACEs and substance misuse among emerging adults is also not fully understood and few studies have investigated potential mediating factors. Methods: We analysed data from the Child Cohort of the Growing Up in Ireland study, a nationally representative longitudinal sample of children recruited at 9 years of age (n = 4,729). Logistic regression was used to examine individual and cumulative ACE exposure relationships with substance use at age 20 years. Mediation analyses were used to assess whether parental and peer relationships and school engagement mediate ACE history associations with substance use behaviours. Results: ACE exposure relationships with current cannabis use, other illicit drug use and problematic drug use were observed. In particular, young adults who had experienced 2 ACEs or 3 + ACEs had an approximate twofold (OR=1.80, 95 % CI: 1.29, 2.51) and approximate three-fold (OR=2.94, 95 % CI: 2.06, 4.19) increased odds of problematic drug use, respectively, when compared to participants who had experienced no ACEs during the study period. Mediation analyses suggested that parent and peer attachment and liking school partially mediate relationships between ACEs and substance use behaviours. Conclusions: Children who have experienced ACEs are at higher risk of future substance use and problematic drug use. In supporting these children, identified mediators such as interpersonal relationships and school engagement may help guide selection of prevention interventions.
13 October 2021 in European Addiction Research
Introduction: Given the increased prevalence of cannabis use in Ireland and increase in cannabis potency, this study aimed to estimate the size of the potential population in Ireland that may be in need of cannabis treatment and the percentage of people with cannabis use disorder (CUD) who actually access treatment. We also compared the profile of those with CUD in the general population to those who receive treatment for their cannabis use to explore whether certain subgroups are more or less likely to enter treatment. Method: This was a retrospective, multi-source database study. Data were obtained from (1) Ireland’s 2014/2015 national general population survey (GPS) on drug use and (2) treatment data from the Irish National Drug Treatment Reporting System (NDTRS) for 2015. The profiles of GPS cases with CUD and NDTRS cases were compared using 2-sided t tests designed for independent samples. Results: The prevalence of last year cannabis use among adults aged 15 and older was 6.5% and the prevalence of CUD was 2.6%, representing 94,515 of the Irish population. A total of 4,761 cases entered treatment for problem cannabis use. NDTRS treatment cases were significantly more likely than GPS cases to be unemployed (63.7% vs. 26.6%) and have no or primary level only educational attainment (56.3% vs. 21.2%). Over half (53.3%) of NDTRS cases first used cannabis before the age of 15 years, compared to 14.7% of CUD cases in the population. Discussion/Conclusion: Our findings suggest that earlier users and those with more complex or disadvantaged lives are more likely to seek treatment. A broad population health approach that engages multiple sectors such as health, social welfare, and education is recommended to ensure that there is increased opportunity for people with CUD to be identified and signposted towards treatment.
8 April 2023 in European Journal of Public Health
There has been considerable debate around the liberalization of cannabis laws in many countries. Given recent changes in cannabis policy, and the current discussion regarding cannabis legalization in Ireland, the aim of this study was to examine changes in attitudes over time towards permitting recreational cannabis use. We analyzed data from Ireland’s 2002/03 (n = 4918); 2006/07 (n = 4967); 2010/11 (n = 5119); 2014/15 (n = 5937); 2019/20 (n = 3982) National Drug Prevalence Surveys. Multivariable logistic regression analyses were used to examine factors associated with being in favour of the use of cannabis for recreational purposes. The results indicate that there is minority support for permitting recreational cannabis use, which ranged from 19.1% in 2006/07 to 29.9% in 2019/20. In multivariable analysis being male and living in Dublin were significant predictors of agreeing with recreational cannabis use, as were being either a recent or past cannabis user, knowing cannabis users, perceiving cannabis use as not being a great risk, and not disapproving of cannabis use. Subjects aged less than 35 years and those who had completed primary education only were significantly less likely to agree with permitting recreational cannabis use. The results from this study indicate that there is minority support for allowing recreational cannabis use. Support was highest among recent cannabis users, consistent with previous studies. The relative lack of support for recreational cannabis use among younger respondents was surprising and warrants further research.
2 July 2025 in BMC Public Health
Increased cocaine supply has coincided with increased global cocaine use. In 2019 Ireland had one of the highest last-year rates of cocaine use in Europe. However, there is a lack of data on the health-related impacts of cocaine use in European countries over time. This retrospective, multi-source database study utilised data from national databases to evaluate the following time trends: (1) prevalence of cocaine use; (2) number of cocaine-related hospital discharges; (3) number of cocaine-related psychiatric hospital admissions; (4) treatment demand for problem cocaine use; and (5) cocaine-related deaths. Joinpoint regression was used to examine change points over time and average annual percentage changes (AAPCs). Last-year cocaine use among 15–64-year-olds increased from 1·1% in 2002/03 to 2·4% in 2022/23. The number of cocaine-related acute hospital discharges per 100,000 population increased from 1·4 in 2000 to 24·3 in 2023 (AAPC: 13·0%; 95% CI: 11·95, 14·84), and psychiatric hospitalisations increased from 0·2 in 2000 to 2·4 in 2022 (AAPC: 11·1%; 95% CI: 9·41, 15·48). Treatment entrants reporting cocaine as a main problem drug increased from 1·5 per 100,000 population in 2000 to 93·2 in 2023 (AAPC: 17·6%; 95% CI: 15·89, 20·74), while cocaine-related deaths increased from 0·3 in 2000 to 5·6 in 2020 (AAPC: 16·9%; 95% CI: 14·71, 21·70). In general, rates of harm increased from 2000 to 2007, decreased until 2011–2013, and since 2013 have increased significantly and consistently. Multiple databases show significant increases in cocaine-related harm since 2000. Responding to cocaine-related health problems and prevention efforts focused on cocaine constitute a public health priority.
15 April 2011 in Alcohol and Alcoholism
Analysis of data from Ireland's Hospital In-Patient Enquiry (HIPE) scheme has revealed a considerable increase in alcohol liver disease (ALD) morbidity and mortality between 1995 and 2007. The rate/100,000 adults (aged ≥15) increased by 190% from 28.3 in 1995 to 82.2 in 2007.